Publicacions 2015

  1. FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.
    Martínez-Aranda A, Hernández V, Guney E, Muixí L, Foj R, Baixeras N, Cuadras D, Moreno V, Urruticoechea A, Gil M, Oliva B, Moreno F, González-Suarez E, Vidal N, Andreu X, Seguí MA, Ballester R, Castella E, Sierra A. Oncotarget. 2015 Dec 29;6(42):44254-73. doi: 10.18632/oncotarget.5471. PMID: 26497551; PMCID: PMC4792555
  2. AMER1 Is a Frequently Mutated Gene in Colorectal Cancer--Letter.
    Mur P, Aiza G, Sanz-Pamplona R, González S, Navarro M, Moreno V, Capellá G, Valle L. Clin Cancer Res. 2015 Nov 1;21(21):4985. doi: 10.1158/1078-0432.CCR-15-1756. PMID: 26527806
  3. [Interval cancers and episode sensitivity in population-based screening programmes for colorectal cancer: a systematic review].
    Domènech X, Garcia M, Benito L, Binefa G, Vidal C, Milà N, Moreno V. Gac Sanit. 2015 Nov-Dec;29(6):464-71. doi: 10.1016/j.gaceta.2015.07.002. Epub: 2015 Sep 2. PMID: 26341155
  4. Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer.
    Sanz-Pamplona R, Lopez-Doriga A, Paré-Brunet L, Lázaro K, Bellido F, Alonso MH, Aussó S, Guinó E, Beltrán S, Castro-Giner F, Gut M, Sanjuan X, Closa A, Cordero D, Morón-Duran FD, Soriano A, Salazar R, Valle L, Moreno V. Clin Cancer Res. 2015 Oct 15;21(20):4709-18. doi: 10.1158/1078-0432.CCR-15-0159. Epub: 2015 Jun 12. PMID: 26071483; PMCID: PMC4609254
  5. Walking, biking or sport: how Spanish women attending breast cancer screening meet physical activity recommendations?
    Peiró-Pérez R, Salas D, Vallés G, Abad-Fernandez MS, Vidal C, Sanchez-Contador Escudero C, Ascunce-Elizaga N, Zubizarreta R, Pedraz C, Pérez-Gómez B, Navarrete-Muñoz EM, Vioque J, Pollán M, DDM-Spain. Eur J Public Health. 2015 Oct;25(5):857-63. doi: 10.1093/eurpub/cku248. Epub: 2015 Mar 12. PMID: 25767095
  6. Hormonal contraception and postmenopausal hormone therapy in Spain: time trends and patterns of use.
    Costas L, Sequera VG, Quesada P, Altzibar JM, Lope V, Pérez-Gómez B, Benavente Y, Martín V, Casabonne D, Robles C, Llorca J, Moreno-Iribas C, Fernandez-Tardón G, Moreno V, Caballero-Granado FJ, Salas D, Jiménez-Moleón JJ, Marcos-Gragera R, Chirlaque MD, Amiano P, Molina AJ, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, de Sanjosé S. Menopause. 2015 Oct;22(10):1138-46. doi: 10.1097/GME.0000000000000487. PMID: 26125537
  7. Dietary flavonoids, lignans and colorectal cancer prognosis.
    Zamora-Ros R, Guinó E, Alonso MH, Vidal C, Barenys M, Soriano A, Moreno V. Sci Rep. 2015 Sep 15;5():14148. doi: 10.1038/srep14148. Epub: 2015 Sep 15. PMID: 26369380; PMCID: PMC4572925
  8. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.
    Rodríguez-Alonso L, Rodríguez-Moranta F, Ruiz-Cerulla A, Lobatón T, Arajol C, Binefa G, Moreno V, Guardiola J. Dig Liver Dis. 2015 Sep;47(9):797-804. doi: 10.1016/j.dld.2015.05.004. Epub: 2015 May 15. PMID: 26055489
  9. Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.
    Seguí N, Mina LB, Lázaro C, Sanz-Pamplona R, Pons T, Navarro M, Bellido F, López-Doriga A, Valdés-Mas R, Pineda M, Guinó E, Vidal A, Soto JL, Caldés T, Durán M, Urioste M, Rueda D, Brunet J, Balbín M, Blay P, Iglesias S, Garré P, Lastra E, Sánchez-Heras AB, Valencia A, Moreno V, Pujana MÁ, Villanueva A, Blanco I, Capellá G, Surrallés J, Puente XS, Valle L. Gastroenterology. 2015 Sep;149(3):563-6. doi: 10.1053/j.gastro.2015.05.056. Epub: 2015 Jun 5. PMID: 26052075
  10. Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.
    Ríos R, Lupiañez CB, Campa D, Martino A, Martínez-López J, Martínez-Bueno M, Varkonyi J, García-Sanz R, Jamroziak K, Dumontet C, Cayuela AJ, Wętek M, Landi S, Rossi AM, Lesueur F, Reis RM, Moreno V, Marques H, Jurczyszyn A, Andersen V, Vogel U, Buda G, Orciuolo E, Jacobsen SE, Petrini M, Vangsted AJ, Gemignani F, Canzian F, Jurado M, Sainz J. Endocr Relat Cancer. 2015 Aug;22(4):545-59. doi: 10.1530/ERC-15-0029. Epub: 2015 Jun 22. PMID: 26099684
  11. Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer.
    Cebola I, Custodio J, Muñoz M, Díez-Villanueva A, Paré L, Prieto P, Aussó S, Coll-Mulet L, Boscá L, Moreno V, Peinado MA. Clin Epigenetics. 2015;7(1):74. doi: 10.1186/s13148-015-0110-4. Epub: 2015 Jul 24. PMID: 26207152; PMCID: PMC4512023
  12. Genome-wide association study of colorectal cancer identifies six new susceptibility loci.
    Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, Melas M, Rennert HS, Shi W, Thomas DC, Van Den Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan BJ, Carlson CS, Chanock SJ, Curtis KR, Fuchs CS, Gala M, Giovannucci EL, Gogarten SM, Hayes RB, Henderson B, Hunter DJ, Jackson RD, Kolonel LN, Kooperberg C, Küry S, LaCroix A, Laurie CC, Laurie CA, Lemire M, Levine D, Ma J, Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono S, West DW, Berndt SI, Bezieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Coetzee GA, Conti DV, Duggan D, Figueiredo JC, Fortini BK, Gallinger SJ, Gauderman WJ, Giles G, Green R, Haile R, Harrison TA, Hoffmeister M, Hopper JL, Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M, Jia WH, Joshi A, Li L, Lindor NM, Matsuo K, Moreno V, Mukherjee B, Newcomb PA, Potter JD, Raskin L, Rennert G, Rosse S, Severi G, Schoen RE, Seminara D, Shu XO, Slattery ML, Tsugane S, White E, Xiang YB, Zanke BW, Zheng W, Le Marchand L, Casey G, Gruber SB, Peters U. Nat Commun. 2015 Jul 7;6():7138. doi: 10.1038/ncomms8138. Epub: 2015 Jul 7. PMID: 26151821; PMCID: PMC4967357
  13. Fecal hemoglobin concentration as a measure of risk to tailor colorectal cancer screening: are we there yet?
    Garcia M, Milà N, Binefa G, Benito L, Gonzalo N, Moreno V. Eur J Cancer Prev. 2015 Jul;24(4):321-7. doi: 10.1097/CEJ.0000000000000090. PMID: 25370684
  14. Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design.
    Castaño-Vinyals G, Aragonés N, Pérez-Gómez B, Martín V, Llorca J, Moreno V, Altzibar JM, Ardanaz E, de Sanjosé S, Jiménez-Moleón JJ, Tardón A, Alguacil J, Peiró R, Marcos-Gragera R, Navarro C, Pollán M, Kogevinas M, MCC-Spain Study Group. Gac Sanit. 2015 Jul-Aug;29(4):308-15. doi: 10.1016/j.gaceta.2014.12.003. Epub: 2015 Jan 19. PMID: 25613680
  15. miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β.
    Bu P, Wang L, Chen KY, Rakhilin N, Sun J, Closa A, Tung KL, King S, Kristine Varanko A, Xu Y, Huan Chen J, Zessin AS, Shealy J, Cummings B, Hsu D, Lipkin SM, Moreno V, Gümüş ZH, Shen X. Nat Commun. 2015 Apr 15;6():6879. doi: 10.1038/ncomms7879. Epub: 2015 Apr 15. PMID: 25872451; PMCID: PMC4399006
  16. Altered pathways and colorectal cancer prognosis.
    Moreno V, Sanz-Pamplona R. BMC Med. 2015 Apr 8;13():76. doi: 10.1186/s12916-015-0307-6. Epub: 2015 Apr 8. PMID: 25885526; PMCID: PMC4389340
  17. Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.
    Campa D, Martino A, Varkonyi J, Lesueur F, Jamroziak K, Landi S, Jurczyszyn A, Marques H, Andersen V, Jurado M, Brenner H, Petrini M, Vogel U, García-Sanz R, Buda G, Gemignani F, Ríos R, Vangsted AJ, Dumontet C, Martínez-López J, Moreno MJ, Stępień A, Wątek M, Moreno V, Dieffenbach AK, Rossi AM, Butterbach K, Jacobsen SE, Goldschmidt H, Sainz J, Hillengass J, Orciuolo E, Dudziński M, Weinhold N, Reis RM, Canzian F. Int J Cancer. 2015 Mar 1;136(5):E351-8. doi: 10.1002/ijc.29101. Epub: 2014 Aug 6. PMID: 25066524
  18. Intrinsic cancer subtypes--next steps into personalized medicine.
    Santos C, Sanz-Pamplona R, Nadal E, Grasselli J, Pernas S, Dienstmann R, Moreno V, Tabernero J, Salazar R. Cell Oncol (Dordr). 2015 Feb;38(1):3-16. doi: 10.1007/s13402-014-0203-7. Epub: 2015 Jan 14. PMID: 25586691
  19. Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.
    Kopetz S, Tabernero J, Rosenberg R, Jiang ZQ, Moreno V, Bachleitner-Hofmann T, Lanza G, Stork-Sloots L, Maru D, Simon I, Capellà G, Salazar R. Oncologist. 2015 Feb;20(2):127-33. doi: 10.1634/theoncologist.2014-0325. Epub: 2015 Jan 5. PMID: 25561511; PMCID: PMC4319631
  20. Dietary inflammatory index and inflammatory gene interactions in relation to colorectal cancer risk in the Bellvitge colorectal cancer case-control study.
    Zamora-Ros R, Shivappa N, Steck SE, Canzian F, Landi S, Alonso MH, Hébert JR, Moreno V. Genes Nutr. 2015 Jan;10(1):447. doi: 10.1007/s12263-014-0447-x. Epub: 2014 Dec 9. PMID: 25488145; PMCID: PMC4259879
  21. Interval cancers in a population-based screening program for colorectal cancer in catalonia, Spain.
    Garcia M, Domènech X, Vidal C, Torné E, Milà N, Binefa G, Benito L, Moreno V. Gastroenterol Res Pract. 2015;2015():672410. doi: 10.1155/2015/672410. Epub: 2015 Feb 24. PMID: 25802515; PMCID: PMC4354714
  22. DNA methylation levels and long-term trihalomethane exposure in drinking water: an epigenome-wide association study.
    Salas LA, Bustamante M, Gonzalez JR, Gracia-Lavedan E, Moreno V, Kogevinas M, Villanueva CM. Epigenetics. 2015;10(7):650-61. doi: 10.1080/15592294.2015.1057672. PMID: 26039576; PMCID: PMC4622514